-
D1.1 MCI to AD Biomarker Deep Dive Analysis for Early Diagnosis (M6)
Detailed mapping of End-users’ Needs, Disease Challenges, and Requirements
-
D1.2 System Architecture, Version 1 (M9)
High-level system architecture and evaluation use cases design
D1.3 System Architecture, Version 2 (M24)
High-level system architecture and evaluation use cases design
-
D2.3 Conjugated MNPs/Aptamers Binding to AD Biomarkers evaluation, Version 1 (M18)
Evaluation results of the binding affinity and specificity to AD biomarkers after optimised functionalisation. - Version 1
D2.4 Conjugated MNPs/Aptamers Binding to AD Biomarkers evaluation, Version 2 (M30)
Evaluation results of the binding affinity and specificity to AD biomarkers after optimised functionalisation. - Version 2
-
D5.1 Clinical Pilot Studies Initiation Package and Ethics check (M12)
Studies registration Information, including approved protocol and other regulatory and ethics documentation.
Ethics check will be carried out by the experts nominated by EC.
D5.2 Pilot Studies Deployment, Version 1 (M30)
Overview of the deployment including recruitment, and overall challenges and mitigation measures. - Version 1
D5.3 Pilot Studies Deployment, Version 2 (M42)
Overview of the deployment including recruitment, and overall challenges and mitigation measures. - Version 2
D5.4 Cross-pilot Comparative Assessment (M48)
Overall evaluation of the 2D-BioPAD studies.
-
D7.2 Data Management Plan, Version 1 (M4)
Procedures set for data collection, processing, monitoring, dissemination, and ethics compliance. - Version 1
D7.3 Data Management Plan, Version 2 (M24)
Procedures set for data collection, processing, monitoring, dissemination, and ethics compliance. - Version 2
D7.4 Data Management Plan, Version 3 (M48)
Procedures set for data collection, processing, monitoring, dissemination, and ethics compliance. - Version 3
